New Paradigms of Coronary Artery Disease

Hibernation, Stunning, Ischemic Preconditioning

Nonfiction, Health & Well Being, Medical, Specialties, Internal Medicine, Cardiology
Cover of the book New Paradigms of Coronary Artery Disease by , Steinkopff
View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart
Author: ISBN: 9783642537936
Publisher: Steinkopff Publication: April 17, 2013
Imprint: Steinkopff Language: English
Author:
ISBN: 9783642537936
Publisher: Steinkopff
Publication: April 17, 2013
Imprint: Steinkopff
Language: English

Detailed analyses of regional myocardial blood flow, function, metabolism and morphology in ischemic and reperfused myocardium have led to the identifi­ cation of important phenomena, i. e. , myocardial hibernation, myocardial stun­ ning and ischemic preconditioning. Both the hibernating and the stunned myocardium characterize viable though dysfunctional as distinguished from necrotic tissue. With the advent of reperfusion procedures, the distinction between reversibly injured, hypofunctional myocardium from irreversibly injured, hypofunctional myocardium is of utmost clinical importance. The pathophysiological distinction of hibernating and stunned myocardium is con­ troversial, but reperfusion is mandatory anyway. Ischemic preconditioning is the most powerful maneuver known so far to delay infarct development. Its clinical significance has been suggested from retrospective analyses of data from patients suffering a myocardial infarction as well as from controlled PTCA studies. Whether or not preconditioning can be achieved pharmacologically in the clinical setting remains to be established. The mechanisms and signal cascade underlying myocardial hibernation, myocardial stunning and ischemic preconditioning are not clear in detail. Over the last year, focussed issues on myocardial hibernation, myocardial stunning and ischemic preconditioning were published in Basic Research in Car­ diology; they have received great interest and a good response. Therefore, these focussed issues are now combined and published as a separate monograph. We express our gratitude once more to all our colleagues who contributed to this monograph, to Ms. Ibkendanz of Steinkopff, and to Ms. Philipp and Mr. Heinrichs from Bayer AG Germany, who supported this additional publication.

View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart

Detailed analyses of regional myocardial blood flow, function, metabolism and morphology in ischemic and reperfused myocardium have led to the identifi­ cation of important phenomena, i. e. , myocardial hibernation, myocardial stun­ ning and ischemic preconditioning. Both the hibernating and the stunned myocardium characterize viable though dysfunctional as distinguished from necrotic tissue. With the advent of reperfusion procedures, the distinction between reversibly injured, hypofunctional myocardium from irreversibly injured, hypofunctional myocardium is of utmost clinical importance. The pathophysiological distinction of hibernating and stunned myocardium is con­ troversial, but reperfusion is mandatory anyway. Ischemic preconditioning is the most powerful maneuver known so far to delay infarct development. Its clinical significance has been suggested from retrospective analyses of data from patients suffering a myocardial infarction as well as from controlled PTCA studies. Whether or not preconditioning can be achieved pharmacologically in the clinical setting remains to be established. The mechanisms and signal cascade underlying myocardial hibernation, myocardial stunning and ischemic preconditioning are not clear in detail. Over the last year, focussed issues on myocardial hibernation, myocardial stunning and ischemic preconditioning were published in Basic Research in Car­ diology; they have received great interest and a good response. Therefore, these focussed issues are now combined and published as a separate monograph. We express our gratitude once more to all our colleagues who contributed to this monograph, to Ms. Ibkendanz of Steinkopff, and to Ms. Philipp and Mr. Heinrichs from Bayer AG Germany, who supported this additional publication.

More books from Steinkopff

Cover of the book PET in Clinical Oncology by
Cover of the book Angiotensin and the Heart by
Cover of the book Ischemic Mitral Incompetence by
Cover of the book Cardiac Glycosides 1785–1985 by
Cover of the book Pathophysiology and Rational Pharmacotherapy of Myocardial Ischemia by
Cover of the book Treatment with Gallopamil by
Cover of the book Cardiac Valve Allografts 1962–1987 by
Cover of the book Nitrates and Nitrate Tolerance in Angina Pectoris by
Cover of the book Congenital Heart Defects by
Cover of the book Cardiac Pacing by
Cover of the book Antimicrobial Prophylaxis in Urology with special reference to the new Quinolones by
Cover of the book Endothelial Mechanisms of Vasomotor Control by
Cover of the book Silent Ischemia by
Cover of the book Cardiac Pacemakers by
Cover of the book Cardiac Valve Allografts by
We use our own "cookies" and third party cookies to improve services and to see statistical information. By using this website, you agree to our Privacy Policy